Evidence map›Paper›PMID 31306631›Full record

ArticleGastroenterology2019

Feasibility of Using Hydrogel Spacers for Borderline-Resectable and Locally Advanced Pancreatic Tumors.

Tossapol Kerdsirichairat, Amol K Narang, Elizabeth Thompson, Seong-Hun Kim, Avani Rao, Kai Ding, Eun Ji Shin

Abstract readVideo-Audio Media
In one paragraph

Article in Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tossapol KerdsirichairatDivision of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Amol K NarangDepartment of Radiation Oncology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Elizabeth ThompsonDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Seong-Hun KimDepartment of Internal Medicine, Chonbuk National University Medical School & Hospital, Jeonju, South Korea.
Avani RaoDepartment of Radiation Oncology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Kai DingDepartment of Radiation Oncology and Molecular Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Eun Ji ShinDivision of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland. Electronic address: eshin3@jhmi.edu.

Funding

Spacer Enabled Robust Radiation Therapy (SERRT)R37CA229417 · NCI · JOHNS HOPKINS UNIVERSITY · PI DING, KAI · 2018 to 2021
$1.5M
NCI NIH HHS R37 CA229417
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

RadiosurgeryAgedCarcinoma, Pancreatic DuctalDuodenumEndosonographyFeasibility StudiesFemaleHumansHydrogelsInjectionsMaleMiddle AgedNeoplasm InvasivenessNeoplasm StagingOrgans at RiskPancreatic NeoplasmsHydrogelsPolyethylene Glycols

Identifiers

PMID31306631
PMCPMC7263852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.